Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer
- PMID: 35766483
- PMCID: PMC9431300
- DOI: 10.1128/spectrum.00013-22
Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer
Abstract
Colorectal cancer (CRC) is the second leading cause of cancer mortality worldwide. The dysbiotic gut microbiota and its metabolite secretions play a significant role in CRC development and progression. In this study, we identified microbial and metabolic biomarkers applicable to CRC using a meta-analysis of metagenomic datasets from diverse geographical regions. We used LEfSe, random forest (RF), and co-occurrence network methods to identify microbial biomarkers. Geographic dataset-specific markers were identified and evaluated using area under the ROC curve (AUC) scores and random effect size. Co-occurrence networks analysis showed a reduction in the overall microbial associations and the presence of oral pathogenic microbial clusters in CRC networks. Analysis of predicted metabolites from CRC datasets showed the enrichment of amino acids, cadaverine, and creatine in CRC, which were positively correlated with CRC-associated microbes (Peptostreptococcus stomatis, Gemella morbillorum, Bacteroides fragilis, Parvimonas spp., Fusobacterium nucleatum, Solobacterium moorei, and Clostridium symbiosum), and negatively correlated with control-associated microbes. Conversely, butyrate, nicotinamide, choline, tryptophan, and 2-hydroxybutanoic acid showed positive correlations with control-associated microbes (P < 0.05). Overall, our study identified a set of global CRC biomarkers that are reproducible across geographic regions. We also reported significant differential metabolites and microbe-metabolite interactions associated with CRC. This study provided significant insights for further investigations leading to the development of noninvasive CRC diagnostic tools and therapeutic interventions. IMPORTANCE Several studies showed associations between gut dysbiosis and CRC. Yet, the results are not conclusive due to cohort-specific associations that are influenced by genomic, dietary, and environmental stimuli and associated reproducibility issues with various analysis approaches. Emerging evidence suggests the role of microbial metabolites in modulating host inflammation and DNA damage in CRC. However, the experimental validations have been hindered by cost, resources, and cumbersome technical expertise required for metabolomic investigations. In this study, we performed a meta-analysis of CRC microbiota data from diverse geographical regions using multiple methods to achieve reproducible results. We used a computational approach to predict the metabolomic profiles using existing CRC metagenomic datasets. We identified a reliable set of CRC-specific biomarkers from this analysis, including microbial and metabolite markers. In addition, we revealed significant microbe-metabolite associations through correlation analysis and microbial gene families associated with dysregulated metabolic pathways in CRC, which are essential in understanding the vastly sporadic nature of CRC development and progression.
Keywords: biomarkers; colorectal cancer; gut dysbiosis; meta-analysis; microbial metabolites; microbiome.
Conflict of interest statement
The authors declare no conflict of interest.
Figures









Similar articles
-
Cross-cohort analysis identifies shared gut microbial signatures and validates microbial risk scores for colorectal cancer.J Transl Med. 2025 Jun 17;23(1):676. doi: 10.1186/s12967-025-06676-z. J Transl Med. 2025. PMID: 40528214 Free PMC article.
-
Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.Gut. 2017 Jan;66(1):70-78. doi: 10.1136/gutjnl-2015-309800. Epub 2015 Sep 25. Gut. 2017. PMID: 26408641
-
Gut Microbial and Associated Metabolite Markers for Colorectal Cancer Diagnosis.Microorganisms. 2023 Aug 8;11(8):2037. doi: 10.3390/microorganisms11082037. Microorganisms. 2023. PMID: 37630597 Free PMC article. Review.
-
Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer.Gastroenterology. 2018 Aug;155(2):383-390.e8. doi: 10.1053/j.gastro.2018.04.028. Epub 2018 May 3. Gastroenterology. 2018. PMID: 29729257
-
Colorectal cancer and gut microbiota studies in China.Gut Microbes. 2023 Jan-Dec;15(1):2236364. doi: 10.1080/19490976.2023.2236364. Gut Microbes. 2023. PMID: 37482657 Free PMC article. Review.
Cited by
-
Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.J Biomed Sci. 2022 Oct 27;29(1):88. doi: 10.1186/s12929-022-00869-0. J Biomed Sci. 2022. PMID: 36303164 Free PMC article.
-
Regulatory effects of oral microbe on intestinal microbiota and the illness.Front Cell Infect Microbiol. 2023 Feb 1;13:1093967. doi: 10.3389/fcimb.2023.1093967. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36816583 Free PMC article. Review.
-
Microbiome Dysbiosis, Dietary Intake and Lifestyle-Associated Factors Involve in Epigenetic Modulations in Colorectal Cancer: A Narrative Review.Cancer Control. 2024 Jan-Dec;31:10732748241263650. doi: 10.1177/10732748241263650. Cancer Control. 2024. PMID: 38889965 Free PMC article. Review.
-
Identifying fecal microbiota signatures of colorectal cancer in a Vietnamese cohort.Front Microbiol. 2024 Dec 24;15:1388740. doi: 10.3389/fmicb.2024.1388740. eCollection 2024. Front Microbiol. 2024. PMID: 39777151 Free PMC article.
-
Multi-omics analysis reveals gut microbiota-metabolite interactions and their association with liver function in autoimmune overlap syndrome.World J Gastroenterol. 2025 Jul 7;31(25):106371. doi: 10.3748/wjg.v31.i25.106371. World J Gastroenterol. 2025. PMID: 40656611 Free PMC article.
References
-
- Mokarram P, Albokashy M, Zarghooni M, Moosavi MA, Sepehri Z, Chen QM, Hudecki A, Sargazi A, Alizadeh J, Moghadam AR, Hashemi M, Movassagh H, Klonisch T, Owji AA, Łos MJ, Ghavami S. 2017. New frontiers in the treatment of colorectal cancer: autophagy and the unfolded protein response as promising targets. Autophagy 13:781–819. doi:10.1080/15548627.2017.1290751. - DOI - PMC - PubMed
-
- Wu XC, Chen VW, Steele B, Ruiz B, Fulton J, Liu L, Carozza SE, Greenlee R. 2001. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992–1997. Cancer 92:2547–2554. doi:10.1002/1097-0142(20011115)92:10<2547::AID-CNCR1606>3.0.CO;2-K. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous